FDA Investigator Wen Ning Chan (Sally)
Wen Ning Chan (Sally) has inspections in 3 countries as of 08 Dec 2023. Wen Ning Chan (Sally) has collaborated with a combined 1946 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
08 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Japan,
Taiwan
Co-Investigator(s):
Alan M Barker,
Alan P Kurtzberg,
Allison C Hunter,
Andrea A Branche,
Andrew J Barrowcliff,
Andrew J Lang,
Anna M Brannen,
Azza Talaat,
Bailey A Uetrecht,
Bethany L Subel,
Brenda C Hamilton,
Brigitte K Hofmann,
Byeongtaek Oh,
Carl Lee,
Chiaochun J Wang,
Christina Capacci Daniel, PhD,
Christina L Bigham,
Christopher T Middendorf,
Cynthia T Cain,
D Yvette Barnett,
Darren S Morgan,
David P Moorhead,
David S Jackson,
Dell S Moller,
Djamila Harouaka,
Dorathy M Eischen,
Dyvette Arline,
Elisa A Nickum,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Frederick M Lochner,
Gam S Zamil,
Genevieve E Ghand,
German Rivera,
Heather A Mccauley,
Hugh M Mcclure, II,
Jacob G Lutz,
James G Marsh,
James Norman,
James P Mcreavey,
Janet L Bowen,
Javier O Vega,
Jazmine N Still,
Jennifer L Gustavus,
Jennifer L Jager,
Jerry J Corwin,
Jessica L Pressley,
Jill R Loeliger,
Jill R Raezer,
Jon P Antoniou,
Jose E Melendez, DDC,
Joshua P Wireman,
Joshua S Hunt,
Joshua Wireman,
Juan Rjimenez Garcia,
Karen M Kondas,
Kathleen D Culver,
Kenneth E Felkley,
Kent C Faul,
Kham Phommachanh,
Klein,
Larry K Austin,
Lauren N Howard,
Lauren N Smith,
Lindsey M Schwierjobann,
Lindsey M Schwierjohann,
Lisa R Hilliar,
Logan T Williams,
Luis M Burgos Medero,
Lynnsey A Renn,
Marcellinus D Dordunoo,
Marianne Allen,
Maribeth G Grattan,
Maribeth G Niesen,
Mark E Parmon,
Mary B Sheets,
Mary E Storch,
Matt D Suedkamp,
Matthew B Casale,
Michael A Charles,
Michael E Clark,
Michael F Sheehan,
Michael L Casner,
Michael P Sheehan,
Mra Davism,
Nadeem I Chaudhry,
Nicholas L Paulin,
Nina Ni,
Noreen Muniz,
Paraluman S Leonin,
Paranthaman Senthamaraikannan,
Phillip M Pontikos,
Pifer,
Rafeeq A Habeeb,
Roy C Stephens,
Samuel A Hamblin,
Scott T Ballard,
Shannon A Gregory,
Sixto M Mercado Rios,
State Agency,
Steven P Eastham,
Sydney S Choi,
Talmane J Fisher,
Tarun D Mehta,
Teresa K Kastner,
Thomas C Woods,
Thomas J Arista,
Tiara Nbrown Crosen,
Tracey L Harris,
Wayne D Mcgrath,
Ying Zhang
Wen Ning Chan (Sally)'s Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more